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Sirs: Haemorrhagic stroke in
young patients is primarily caused
by elevated blood pressure, under-
lying vascular structural abnor-
malities, cardiac embolism or mi-
graine [1–3]. Vasculitis may be a
possible but uncommon aetiology
of ischemic stroke in patients aged
less than 45 years [4] and rarely
causes brain haemorrhage [5, 6].
We report on a patient who pre-
sented with haemorrhagic stroke
as the initial symptom of Wegener
granulomatosis (WG).
In March 2003, a 42 year old
male smoker presented with acute
onset of a right sensorimotor
hemisyndrome accompanied by
motor aphasia. Magnetic resonance
imaging (MRI) revealed a haemor-
rhagic stroke in the left basal gan-
glia, without underlying ischaemic
damage (Figure). No vascular mal-
formation, aneurysm, tumour or
venous thrombosis was observed.
Acutely, blood pressure was
180/90 mmHg but funduscopy as
well as urinary sediment did not





mild inflammatory signs and im-
munological tests revealed elevated
c-ANCA and anti PR-3 antibodies
(Table); p-ANCA, x-ANCA, anti
MPO antibodies, as well as CSF
analysis were negative. The patient
had no symptoms or signs charac-
teristic of WG: renal function, uri-
nary sediment, thorax radiography
and otorhinolaryngological exami-
nation were normal. Three months
later, the patient had no symptoms,
normal inflammatory parameters
and still elevated autoantibodies
(Table). In November 2003, he de-
veloped acute respiratory distress,
fever, oral ulcers, epistaxis and
arthralgia. Lung CT showed sub-
pleural nodules and infiltrates and
bronchoscopic bronchoalveolar
lavage revealed intraalveolar haem-
orrhage (30 % haemosidero-
phages). Microbiological analysis
for pneumocystis, nocardia, my-
coses, mycobacteries and CMV was
negative. Tongue and gingival
biopsy specimens showed non
specific ulcers. Glomerular micro-
haematuria (95 RBC/field) and
mild proteinuria (0.3 g/l proteins)
were now observed. Renal biopsy
revealed an impaired immunity
crescentic extracapillary glomeru-
lonephritis without granulomatous
lesions; c-ANCA and anti PR-3
antibodies elevation persisted and
inflammatory parameters had
reappeared (Table). Three out of
four ACR classification criteria [7]
were positive, so the diagnosis of
WG was established. The patient
was treated with intravenous
steroids and cyclophosphamide.
One month later, inflammatory
signs as well as autoantibodies nor-
malised and all systemic signs and
symptoms had resolved completely.
This patient presented with
haemorrhagic stroke; he did not




Fig. T1 (left) and FLAIR (right) weighted brain MRI show predominantly hypointense lesion in the left lenticu-
lar nucleus (left) with a hyperintense oedematous ring surrounding the lesion (right)
Table Comparative evolution of autoantibodies levels, inflammatory parameters, and clinical features
March 2003 July 2003 November 2003 December 2003
Anti c-ANCA (n. r. < 1/20) 1/320* 1/320* 1/320* –
Anti PR3 (n. r. < 20 U) 73U* 67U* 75U* 21U
ESR (n. r. < 10 mm/h) 33 mm/h* 10 mm/h 40 mm/h* 18 mm/h
CRP (n. r. < 10 mg/l) 31 mg/l* < 2 mg/l 70 mg/l*
Symptoms Haemorrhagic None Fever, arthralgia, ENT, None
stroke lung, kidney disease
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have the clinical picture of WG,
but-ANCA and anti PR-3 antibod-
ies were significantly elevated and
a mild inflammatory syndrome
was present. Eight months later, he
developed specific symptoms and
signs of the disease without in-
volvement of the CNS. The imaging
studies excluded any vascular or
cardiac abnormality, and the pa-
tient had no objective signs of un-
derlying arterial hypertension or a
history of migraine. Therefore, we
believe that his haemorrhagic
stroke represented an unusual ini-
tial manifestation of WG.
WG is a primary small vessel
vasculitis. Its immunological hall-
mark is a diffuse cytoplasmic pat-
tern of antibodies (c-ANCA) that
are usually directed against pro-
teinase 3 (anti PR3) [13]. Concomi-
tant testing of c-ANCA and anti
PR3 antibodies can minimize false
positive results [14]. In our patients
both tests were consistently highly
positive and normalised only after
treatment. This case confirms that
WG may rarely be responsible for
cerebrovascular disease in young
adults [8–12] and that intracerebral
haematoma can exceptionally oc-
cur [8, 12]. Moreover, it illustrates
that WG may reveal itself exclu-
sively through neurological mani-
festations, without typical systemic
signs. In addition, though severe
CNS involvement has been de-
scribed in ANCA negative patients
[15], it suggests that autoantibodies
(c-ANCA/anti-PR3) represent a
valuable marker of WG even before
its clinical manifestation.
For all these reasons, we suggest
that WG should be considered as a
possible cause of haemorrhagic
stroke in a young patient in the ab-
sence of other causes. A positive c-
ANCA/PR-3 testing should lead to
a close clinical and paraclinical fol-
low up, in order to prevent a cata-
strophic outcome of this poten-
tially serious disease.
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